CVE-2022-38801 — MEDIUM (5.4)

Q: What is CVE-2022-38801?

CVE-2022-38801 is a vulnerability with a CVSS score of 5.4 (MEDIUM). In Zkteco BioTime < 8.5.3 Build:20200816.447, an employee can hijack an administrator session and cookies using blind cross-site scripting.

Q: How severe is CVE-2022-38801?

CVE-2022-38801 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2022-38801?

Check the references section above for vendor advisories and patch information. Affected products include: Zkteco Biotime.

Vulnerability Description

In Zkteco BioTime < 8.5.3 Build:20200816.447, an employee can hijack an administrator session and cookies using blind cross-site scripting.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Zkteco	Biotime	< 8.5.4

Related Weaknesses (CWE)

CWE-79

References

https://gist.github.com/hamoshwani/5ac860dd6757440174f446c62b24653fThird Party Advisory
https://www.zkteco.com/Product
https://gist.github.com/hamoshwani/5ac860dd6757440174f446c62b24653fThird Party Advisory
https://www.zkteco.com/Product

FAQ

What is CVE-2022-38801?

CVE-2022-38801 is a vulnerability with a CVSS score of 5.4 (MEDIUM). In Zkteco BioTime < 8.5.3 Build:20200816.447, an employee can hijack an administrator session and cookies using blind cross-site scripting.

How severe is CVE-2022-38801?

CVE-2022-38801 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-38801?

Check the references section above for vendor advisories and patch information. Affected products include: Zkteco Biotime.